Notice of Intent - Sole Source for Next Generation Sequencing for Illumina Reagents for HLA Typing and Organ Transplantation
SAM.GOV Due: June 4, 2025 at 09:00 PM UTC
In-Active Special Notice Source Url

Summary

The Defense Health Agency (DHA) is planning to award a firm fixed price contract on a sole source basis to Illumina, Inc. for the provision of Next Generation Sequencing reagents specifically for high resolution analysis related to organ transplant donors and recipients. This contract will involve the acquisition of the MiniSeq Mid Output Kit and PhiX Control v3, which will be utilized with existing Illumina equipment. This opportunity is not open for competitive proposals, and interested parties may express their capabilities to fulfill the requirements by a specified deadline. Contractors with experience in medical sequencing technology and a capacity to supply the specified reagents are encouraged to respond.
Description

The Defense Health Agency (DHA) Healthcare Contracting Division Northeast (HCD-NE), on behalf of the Surgery-Organ Transplant Service Department of the Walter Reed National Military Medical Center (WRNMMC) intends to award a firm fixed price contract on a sole source basis to Illumina, Inc. (CAGE

Entities
DOD
Department of Defense
DHA(
Defense Health Agency
NAICS
334516
Set Aside
None
Place of Performance
Bethesda , Maryland 20889
Point of Contact
Full Name Email Phone Type
Kendall Spann [email protected] primary